7607 Competitors

Stocks . Taiwan . 
Stock . 7607
7607 Stock   19.15  0.35  1.86%   
7607 competes with EPS Bio, Taiwan Advanced, UniPharma, Pharmigene, and Welgene Biotech; as well as few others. Analyzing 7607 competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of 7607 to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.

7607 vs 4170 Correlation

Moving against 7607 Stock

  0.542330 Taiwan SemiconductorPairCorr
  0.520050 YuantaP shares TaiwanPairCorr
  0.510057 Fubon MSCI TaiwanPairCorr
  0.50053 YuantaP shares TaiwanPairCorr
  0.482412 Chunghwa TelecomPairCorr

7607 Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between 7607 and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of 7607 and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of 7607 does not affect the price movement of the other competitor.

High positive correlations

6734
+ 0.78
4183
6734
+ 0.7
6621
6734
+ 0.58
1781
1781
+ 0.53
6621
6621
+ 0.52
4183
6661
+ 0.47
6621
  

High negative correlations

4170
- 0.35
4183
1781
- 0.33
7595
1781
- 0.31
4115
6734
- 0.3
6797
6621
- 0.29
6797
4170
- 0.27
6621

Risk-Adjusted Indicators

There is a big difference between 7607 Stock performing well and 7607 Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze 7607's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
4183  1.02 (0.16) 0.00 (1.84) 0.00 
 0.00 
 2.64 
(2.35)
 8.43 
6797  2.19  0.01 (0.01) 0.67  3.31 
(2.52)
 4.65 
(7.10)
 22.74 
6621  1.14  0.21  0.08 (1.22) 1.29 
(1.44)
 2.81 
(2.02)
 9.14 
7595  1.46 (0.07) 0.00  0.67  0.00 
 0.00 
 4.12 
(3.82)
 7.95 
4115  1.33  0.03  0.00  0.16  1.49 
(2.30)
 3.95 
(3.57)
 8.68 
6661  0.88 (0.04) 0.00 (0.57) 0.00 
 0.00 
 2.33 
(2.05)
 7.33 
6758  0.63 (0.06) 0.00  0.63  0.00 
 0.00 
 1.62 
(3.97)
 8.78 
1781  0.73 (0.07) 0.00 (0.44) 0.00 
 0.00 
 0.91 
(1.33)
 10.60 
6734  2.05 (0.17) 0.00  0.33  0.00 
 0.00 
 4.13 
(4.76)
 15.82 
4170  2.25  0.03 (0.02)(0.05) 2.97 
(2.51)
 4.44 
(3.81)
 19.83 

7607 Competitive Analysis

The better you understand 7607 competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, 7607's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across 7607's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
7607 4183 6797 6621 7595 4115 6661 6758 1781 6734
 1.86 
 19.15 
7607
 0.31 
 16.20 
EPS
 1.31 
 15.10 
Taiwan
 0.38 
 13.10 
UniPharma
 5.13 
 10.05 
Pharmigene
 3.95 
 8.42 
Sunder
 1.06 
 19.05 
Welgene
 0.52 
 38.50 
6758
 0.82 
 12.05 
Health
 3.09 
 6.34 
IXensor
Market Volatility
(90 Days Market Risk)
Not too volatile
Very steady
Somewhat reliable
Not too volatile
Not too volatile
Somewhat reliable
Very steady
Very steady
Not too volatile
Slightly risky
Market Performance
(90 Days Performance)
Weakest
Weakest
Weakest
Fair
Weakest
Weak
Weakest
Weakest
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Unknown
Low
Low
Low
Low
Unknown
Low
Low
Fair
High
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Strong Sell
Cautious Hold
Strong Sell
Current Ratio
N/A
2.88
2.62
9.6
14.16
N/A
3.89
N/A
N/A
4.71
Profit Margin
N/A
9.33
33.89
-39.93
-11.06
N/A
N/A
N/A
N/A
N/A
EBITDA
N/A
46.92 M
809.69 M
(15.17 M)
(8.73 M)
N/A
33.05 M
N/A
N/A
(92.19 M)
Operating Margin
N/A
7.56
40.21
-14.87
-13.68
N/A
N/A
N/A
N/A
-696.46
Current Valuation
N/A
345.41 M
945.75 M
286.35 M
717.33 M
N/A
N/A
N/A
N/A
737.24 M
Price To Book
N/A
1.36
1.34
1.23
2.49
N/A
N/A
N/A
N/A
9.15
Beta
N/A
1.3
N/A
1.18
N/A
N/A
0.33
N/A
N/A
0.99
Number Of Employees
N/A
121
N/A
42
N/A
N/A
11
N/A
7
N/A
Shares Outstanding
N/A
23.8 M
23.17 M
35.2 M
43.47 M
N/A
N/A
13.47 M
N/A
49.41 M
Cash Flow From Operations
N/A
37.37 M
789.25 M
(17.18 M)
(12.78 M)
N/A
34.62 M
N/A
N/A
(70.8 M)
Total Debt
N/A
141.01 M
553.23 M
16.82 M
21.63 M
N/A
30.42 M
N/A
N/A
3.8 M
Return On Equity
N/A
14.88
50.59
-14.19
-4.15
N/A
N/A
N/A
N/A
-89.84
Z Score
N/A
1.2
1.2
16.2
28.2
N/A
11.4
N/A
N/A
N/A
Return On Asset
N/A
4.42
19.95
-2.96
-2.79
N/A
N/A
N/A
N/A
-52.32
Book Value Per Share
N/A
12.43
44.83
10.77
9.42
N/A
13.6
N/A
N/A
1.6
Debt To Equity
N/A
47.6
0.35
0.044
0.052
N/A
0.095
N/A
N/A
0.047
Last Dividend Paid
N/A
0.7
6.0
N/A
N/A
N/A
1.1
2.5
N/A
N/A
Market Capitalization
N/A
402.22 M
1.39 B
464.65 M
1.02 B
N/A
591.92 M
693.76 M
538.08 M
723.78 M
Price To Earning
N/A
9.74
1.98
N/A
N/A
N/A
24.19
N/A
N/A
N/A
Price To Sales
N/A
0.9
0.74
3.35
10.06
N/A
N/A
N/A
N/A
51.55
Net Income
N/A
41.47 M
636.96 M
(55.35 M)
(11.21 M)
N/A
22.38 M
N/A
N/A
(89.69 M)
Earnings Per Share
N/A
1.74
30.37
-1.57
-0.33
N/A
1.05
N/A
N/A
-1.55
Revenue
N/A
444.68 M
1.88 B
138.64 M
101.35 M
N/A
N/A
N/A
N/A
14.04 M
Cash And Equivalents
N/A
202.58 M
1.37 B
188.09 M
297.48 M
N/A
239.66 M
N/A
N/A
31.28 M
Cash Per Share
N/A
8.51
45.56
5.34
6.84
N/A
10.28
N/A
N/A
0.6
Gross Profit
N/A
95.71 M
1.07 B
69.32 M
44.29 M
N/A
N/A
N/A
N/A
4.5 M
Day Typical Price
18.97
16.2
15.02
13.18
10.03
8.42
19.05
38.48
12.05
6.28
Accumulation Distribution
0.039
0.0062
0.0552
0.0407
0.005
N/A
N/A
0.0013
0.0083
0.0783
Market Facilitation Index
0.75
0.1
0.85
0.55
0.05
N/A
N/A
0.05
0.1
0.51
Daily Balance Of Power
0.4667
0.5
(0.24)
(0.09)
9.8
9.2 T
9.2 T
4.0
(1.00)
0.3725
Period Momentum Indicator
0.35
0.05
(0.20)
(0.05)
0.49
0.32
0.2
0.2
(0.10)
0.19
Rate Of Daily Change
1.02
1.0
0.99
1.0
1.05
1.04
1.01
1.01
0.99
1.03
Day Median Price
18.88
16.2
14.98
13.23
10.03
8.42
19.05
38.48
12.05
6.26
Price Action Indicator
0.45
0.025
0.025
(0.15)
0.27
0.16
0.1
0.13
(0.05)
0.18
Relative Strength Index
N/A
38.25
47.23
N/A
N/A
N/A
53.08
N/A
57.7
50.46
Coefficient Of Variation
(3,154)
(1,011)
14059.08
779.2
(3,043)
2750.12
(4,561)
(2,401)
(2,845)
(1,430)
Mean Deviation
1.68
1.02
2.19
1.14
1.46
1.33
0.8799
0.6275
0.725
2.05
Jensen Alpha
(0.08)
(0.16)
0.0135
0.2066
(0.07)
0.0348
(0.04)
(0.06)
(0.07)
(0.17)
Total Risk Alpha
(0.33)
(0.30)
(0.31)
0.0461
(0.27)
(0.12)
(0.16)
(0.19)
(0.20)
(0.48)
Sortino Ratio
N/A
N/A
(0.01)
0.0751
N/A
(0)
N/A
N/A
N/A
N/A
Downside Variance
N/A
N/A
17.52
2.88
N/A
4.75
N/A
N/A
N/A
N/A
Standard Deviation
2.53
1.51
3.52
1.6
2.05
1.92
1.29
1.3
1.5
2.89
Kurtosis
2.89
1.85
3.42
1.93
0.2139
0.4731
1.67
7.46
29.5
1.76
Potential Upside
4.63
2.64
4.65
2.81
4.12
3.95
2.33
1.62
0.9132
4.13
Treynor Ratio
0.4715
(1.84)
0.6708
(1.22)
0.6726
0.1637
(0.57)
0.6322
(0.44)
0.3295
Maximum Drawdown
13.34
8.43
22.74
9.14
7.95
8.68
7.33
8.78
10.6
15.82
Variance
6.42
2.27
12.38
2.57
4.2
3.67
1.67
1.69
2.26
8.36
Market Risk Adjusted Performance
0.4815
(1.83)
0.6808
(1.21)
0.6826
0.1737
(0.56)
0.6422
(0.43)
0.3395
Risk Adjusted Performance
(0.02)
(0.07)
0.0131
0.0994
(0.02)
0.0328
(0.01)
(0.03)
(0.02)
(0.04)
Skewness
0.8015
0.5353
0.2113
0.2076
0.3566
0.1939
0.444
(0.86)
4.44
0.2861
Semi Deviation
N/A
N/A
3.31
1.29
N/A
1.49
N/A
N/A
N/A
N/A
Information Ratio
(0.06)
(0.15)
(0.02)
0.0795
(0.07)
(0)
(0.08)
(0.10)
(0.09)
(0.1)
Value At Risk
(4.65)
(2.35)
(7.10)
(2.02)
(3.82)
(3.57)
(2.05)
(3.97)
(1.33)
(4.76)
Expected Short fall
N/A
N/A
(2.52)
(1.44)
N/A
(2.30)
N/A
N/A
N/A
N/A
Downside Deviation
N/A
N/A
4.19
1.7
N/A
2.18
N/A
N/A
N/A
N/A
Semi Variance
N/A
N/A
10.98
1.65
N/A
2.21
N/A
N/A
N/A
N/A

7607 Competition Performance Charts

Five steps to successful analysis of 7607 Competition

7607's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by 7607 in relation to its competition. 7607's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of 7607 in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact 7607's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to 7607, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your 7607 position

In addition to having 7607 in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Penny Thematic Idea Now

Penny
Penny Theme
Solid stocks, funds or ETFs with below average market capitalization and typicl daily price below 2. The Penny theme has 29 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Penny Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for 7607 Stock Analysis

When running 7607's price analysis, check to measure 7607's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 7607 is operating at the current time. Most of 7607's value examination focuses on studying past and present price action to predict the probability of 7607's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 7607's price. Additionally, you may evaluate how the addition of 7607 to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY